Remarkably, the drug molecule dasatinib targets 3 genes of the INPAR-N, including FYN. Dasatinib may induce neutropenia along with having potential anti-inflammatory and immunosuppressive effects [41]. Here, FYN is linked to Decreased total neutrophil count.